Daiichi Sankyo and GSK to Establish Vaccines Joint Venture in Japan
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 3 (Table of Contents)
Published: 14 Mar-2012
DOI: 10.3833/pdr.v2012.i3.1699 ISSN: 1756-7874
Section: Joint Venture
Fulltext:
Abstract
Daiichi Sankyo and GlaxoSmithKline have agreed to form a 50-50 joint venture for the development and distribution of vaccines in Japan...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
Login Problems
RSS